Recombinant adeno-associated virus vectors (rAAVs) symbolize a dependable software for fundamental and translational analysis, whereas rAAVs are additionally making strides in early medical trials as autos for gene switch. Their low immunogenicity, tissue tropism, and relative security on account of their low fee of genomic integration symbolize key options, making rAAVs promising devices as vectors for future gene remedy approaches.
Particularly, for cardiovascular gene remedy, rAAVs seem superior to different vector programs resembling lenti– and adenoviral vectors as a result of ease of undertaking long-term cardiac expression of goal genes and the decreased danger of scary immune responses or triggering malignancies via genomic integration. Nevertheless, main obstacles stay to be resolved if rAAVs are to attain their full potential as gene remedy vectors in medical trials. The primary hurdles prohibiting their sustained success are their restricted capability to hold transgenes of bigger sizes, the prevalence of neutralizing antibodies within the common inhabitants, and their tissue specificity, which leaves room for enchancment. This assessment discusses the properties of rAAV that make them helpful instruments in experimental research and the remedy of heart problems in sufferers.
CAR-T cell remedy that targets floor antigens to kill tumor cells particularly has not too long ago grow to be one other cornerstone in tumor immunotherapy. On this examine, a lentiviral expression plasmid of CAR focusing on human epidermal development issue receptor 2 (HER2) was constructed by genetic engineering.
The recombinant plasmid was co-transfected with different packaging plasmids into HEK293T cells by calcium phosphate precipitation to generate lenti-car, that are CAR lentiviral particles. HER2-specific CAR-T cells have been obtained by transducing human peripheral blood mononuclear cells with lenti-car.
Insect (meals) allergy and allergens.
Bugs symbolize an alternate for meat and fish in satisfying the growing demand for sustainable sources of vitamin. Roughly two billion folks globally eat bugs. They’re notably well-liked in Asia, Latin America, and Africa. Most analysis on insect allergy has focussed on occupational or inhalation allergy. Analysis on insect meals security, together with allergenicity, is subsequently of nice significance.
The target of this assessment is to offer an outline of instances reporting allergy following insect ingestion, research on meals allergy to bugs, proteins concerned in insect allergy together with cross-reactive proteins, and the likelihood to change the allergenic potential of bugs by meals processing and digestion. Meals allergy to bugs has been described for silkworm, mealworm, caterpillars, Bruchus lentis, sago worm, locust, grasshopper, cicada, bee, Clanis bilineata, and the meals additive carmine, which is derived from feminine Dactylopius coccus bugs.
For cockroaches, that are additionally edible bugs, solely research on inhalation allergy have been described. Varied insect allergens have been recognized together with tropomyosin and arginine kinase, that are each pan-allergens identified for his or her cross-reactivity with homologous proteins in crustaceans and home mud mite. Cross-reactivity and/or co-sensitization of insect tropomyosin and arginine kinase has been demonstrated in home mud mite and seafood (e.g. prawn, shrimp) allergic sufferers. As well as, many different (allergenic) species (varied non-edible bugs, arachnids, mites, seafoods, mammals, nematoda, trematoda, vegetation, and fungi) have been recognized with sequence alignment evaluation to point out potential cross-reactivity with allergens of edible bugs.
It was additionally proven that thermal processing and digestion didn’t get rid of insect protein allergenicity. Though purified pure allergens are scarce and yields are low, recombinant allergens from cockroach, silkworm, and Indian mealmoth are available, giving alternatives for future analysis on diagnostic allergy checks and vaccine candidates.
New Strategy for Differentiation of Bone Marrow Mesenchymal Stem Cells Towards Chondrocyte Cells With Overexpression of MicroRNA-140.
Mesenchymal stem cells are broadly stimulated by reworking development issue beta-3 (TGFβ3) for chondrocyte differentiation. The target of our examine was to determine a brand new methodology for differentiation of human mesenchymal stem cells towards chondrocyte by overexpression of MicroRNA-140 (miR-140), and in addition this methodology was in contrast with methodology of induction with TGFβ3 in high-cell density tradition programs. Mesenchymal stem cells have been harvested from bone marrow of human. We ready vectors after which was used for recombinant Lenti virus manufacturing in HEK-293 cell.
Transducted cells have been cultured in monolayer tradition system and have been harvested after days 7, 14, and 21. Actual time polymerase chain response (RT-PCR) was carried out to judge the cartilage-specific genes within the mRNA ranges. Additionally, in an effort to affirm our outcomes, we now have performed immunocytochemistry approach.
Bone marrow mesenchymal stem cells (BMSCs) have been transducted with recombinant Lenti virus, and miR-140 was expressed. Immunocytochemical methodology confirmed the differentiation of BMSC towards chondrocyte with dealing with cartilage matrix genes. Additionally real-time PCR confirmed that after expression of miR-140 in transducted BMSCs considerably elevated gene expression of collagen sort II and aggrecan and downregulated expression of collagen sort I compared with the mRNA ranges measured in nontransducted BMSCs. These outcomes have been suitable in contrast with TGFβ3 induction methodology as management optimistic.
Mouse Anti-Human TIE-2 |
|
MBS690125-01mg |
MyBiosource |
0.1mg |
EUR 430 |
Mouse Anti-Human TIE-2 |
|
MBS690125-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1645 |
Mouse Anti-Human TIE-2 |
|
MBS690553-005mg |
MyBiosource |
0.05mg |
EUR 430 |
Mouse Anti-Human TIE-2 |
|
MBS690553-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1645 |
Mouse Anti-Human TIE-2 |
|
MBS690729-005mg |
MyBiosource |
0.05mg |
EUR 430 |
Mouse Anti-Human TIE-2 |
|
MBS690729-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1645 |
Mouse Anti-Human TIE-2 |
|
MBS690909-01mg |
MyBiosource |
0.1mg |
EUR 430 |
Mouse Anti-Human TIE-2 |
|
MBS690909-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1645 |
Mouse Anti-Human TIE-2 |
|
MBS691042-01mg |
MyBiosource |
0.1mg |
EUR 430 |
Mouse Anti-Human TIE-2 |
|
MBS691042-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1645 |
Mouse Anti-Human TIE-2-PE |
|
MBS690272-0025mg |
MyBiosource |
0.025mg |
EUR 310 |
Mouse Anti-Human TIE-2-PE |
|
MBS690272-5x0025mg |
MyBiosource |
5x0.025mg |
EUR 1110 |
Mouse Anti-Human TIE-2-PE |
|
MBS692361-005mg |
MyBiosource |
0.05mg |
EUR 450 |
Mouse Anti-Human TIE-2-PE |
|
MBS692361-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1725 |
Mouse Anti-Human TIE-2-FITC |
|
MBS690466-0025mg |
MyBiosource |
0.025mg |
EUR 310 |
Mouse Anti-Human TIE-2-FITC |
|
MBS690466-5x0025mg |
MyBiosource |
5x0.025mg |
EUR 1110 |
Mouse Anti-Human TIE-2-FITC |
|
MBS692360-005mg |
MyBiosource |
0.05mg |
EUR 450 |
Mouse Anti-Human TIE-2-FITC |
|
MBS692360-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1725 |
Mouse Anti-Human TIE-1 |
|
MBS690314-005mg |
MyBiosource |
0.05mg |
EUR 430 |
Mouse Anti-Human TIE-1 |
|
MBS690314-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1645 |
Mouse Anti-Human TIE-1 |
|
MBS690445-01mg |
MyBiosource |
0.1mg |
EUR 430 |
Mouse Anti-Human TIE-1 |
|
MBS690445-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1645 |
Mouse Anti-Human TIE-1 |
|
MBS690502-01mg |
MyBiosource |
0.1mg |
EUR 430 |
Mouse Anti-Human TIE-1 |
|
MBS690502-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1645 |
Mouse TIE-2 Fc Chimera (TIE-2 Fc) Protein |
|
abx073610-100ml |
Abbexa |
100 ml |
EUR 225 |
Mouse TIE-2, soluble |
|
MBS691530-001mg |
MyBiosource |
0.01mg |
EUR 255 |
Mouse TIE-2, soluble |
|
MBS691530-5x001mg |
MyBiosource |
5x0.01mg |
EUR 865 |
Mouse TIE-2, soluble |
|
MBS691557-005mg |
MyBiosource |
0.05mg |
EUR 430 |
Mouse TIE-2, soluble |
|
MBS691557-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1645 |
Anti-Mouse TIE-2 Antibody |
|
103-M55 |
ReliaTech |
100 µg |
EUR 399 |
|
Description: Tie-2 is an endothelial-specific receptor tyrosine kinase and a receptor for angiopoietins. Tie-2 is predominantly expressed in the endothelium and it is likely involved in the regulation of vascular maturation and stability. |
Anti-Mouse TIE-2 Antibody |
|
103-PA111S |
ReliaTech |
100 µg |
EUR 126 |
|
Description: Tie-1/Tie and Tie-2/Tek are receptor tyrosine kinases with unique structural characteristics including two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains, followed by three fibronectin type III-like repeats in the extracellular region, and a split tyrosine kinase domain in the cytoplasmic region. Tie-2 is involved in vascular stabilization and remodeling. Although less well understood, Tie-1 may also act as an ANG receptor, possibly in complex with Tie-2. Human Tie-2 cDNA encodes a 1124 amino acid (aa) residue precursor protein with an 18 residue putative signal peptide, a 727 residue extracellular domain and a 354 residue cytoplasmic domain. Tie-2 is a receptor for the angiopoietin (ANG) family: ANG-1, ANG-2, and ANG-3 (mouse)/-4 (human). Ang-2 has been reported to act as an antagonist for Ang-1. Mice engineered to overexpress Ang-2 or to lack Ang-1 or Tie-2 display similar angiogenesis defects. |
Tie-2 Mouse ELISA Kit |
|
MBS355356-5x96Tests |
MyBiosource |
5x96Tests |
EUR 2235 |
Tie-2 Mouse ELISA Kit |
|
MBS355356-96Tests |
MyBiosource |
96Tests |
EUR 495 |
Mouse TIE-2/Fc Chimera, soluble |
|
MBS691585-01mg |
MyBiosource |
0.1mg |
EUR 430 |
Mouse TIE-2/Fc Chimera, soluble |
|
MBS691585-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1645 |
Mouse TIE-2/Fc Chimera, soluble |
|
MBS692080-002mg |
MyBiosource |
0.02mg |
EUR 255 |
Mouse TIE-2/Fc Chimera, soluble |
|
MBS692080-5x002mg |
MyBiosource |
5x0.02mg |
EUR 865 |
Recombinant Mouse TIE-2 Fc Chimera |
|
7-04192 |
CHI Scientific |
1µg |
Ask for price |
Recombinant Mouse TIE-2 Fc Chimera |
|
7-04193 |
CHI Scientific |
3µg |
Ask for price |
Recombinant Mouse TIE-2 Fc Chimera |
|
7-04194 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Mouse TIE-2 Fc Chimera |
|
MBS142795-0002mg |
MyBiosource |
0.002mg |
EUR 240 |
Recombinant Mouse TIE-2 Fc Chimera |
|
MBS142795-001mg |
MyBiosource |
0.01mg |
EUR 310 |
Recombinant Mouse TIE-2 Fc Chimera |
|
MBS142795-1mg |
MyBiosource |
1mg |
EUR 3975 |
Recombinant Mouse TIE-2 Fc Chimera |
|
MBS142795-5x1mg |
MyBiosource |
5x1mg |
EUR 17550 |
Mouse TIE-2, soluble Recombinant Protein |
|
S01-M43 |
ReliaTech |
10 µg |
EUR 68.25 |
|
Description: Recombinant mouse soluble TIE-2 was fused with a 6x His-tag at the C-terminus. The soluble receptor protein consists of the full extracellular domain (Ala23-Ala737). Mouse sTIE-2 monomer has a calculated molecular mass of approximately 79,86 kDa. As a result of glycosylation, the recombinant protein migrates as an approximately 95 kDa protein in SDS-PAGE under reducing conditions. TIE-1 (tyrosine kinase with Ig and EGF homology domains 1) and TIE-2/Tek comprise a receptor tyrosine kinase (RTK) subfamily with unique structural characteristics: two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains and followed by three fibronectin type III-like repeats in the extracellular region and a split tyrosine kinase domain in the cytoplasmic region. These receptors are expressed primarily on endothelial and hematopoietic progenitor cells and play critical roles in angiogenesis, vasculogenesis and hematopoiesis. |
Mouse TIE-2, soluble Recombinant Protein |
|
S01-M44 |
ReliaTech |
50 µg |
EUR 189 |
|
Description: Recombinant mouse soluble TIE-2 was fused with a 6x His-tag at the C-terminus. The soluble receptor protein consists of the full extracellular domain (Ala23-Ala737). Mouse sTIE-2 monomer has a calculated molecular mass of approximately 79,86 kDa. As a result of glycosylation, the recombinant protein migrates as an approximately 95 kDa protein in SDS-PAGE under reducing conditions. TIE-1 (tyrosine kinase with Ig and EGF homology domains 1) and TIE-2/Tek comprise a receptor tyrosine kinase (RTK) subfamily with unique structural characteristics: two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains and followed by three fibronectin type III-like repeats in the extracellular region and a split tyrosine kinase domain in the cytoplasmic region. These receptors are expressed primarily on endothelial and hematopoietic progenitor cells and play critical roles in angiogenesis, vasculogenesis and hematopoiesis. |
PE anti-mouse CD202b (Tie-2, CD202) |
|
E16FMP202b-050U |
EnoGene |
50 μg |
EUR 476.67 |
|
Description: Available in various conjugation types. |
PE anti-mouse CD202b (Tie-2, CD202) |
|
E16FMP202b-100U |
EnoGene |
100 μg |
EUR 953.33 |
|
Description: Available in various conjugation types. |
PE anti-mouse CD202b (Tie-2, CD202) |
|
E16FMP202b-200U |
EnoGene |
200 μg |
EUR 1278.33 |
|
Description: Available in various conjugation types. |
PE anti-mouse CD202b (Tie-2, CD202) |
|
GT03154 |
Sony |
200 µg |
Ask for price |
|
|
PE anti-mouse CD202b (Tie-2, CD202) |
|
GT03153 |
Sony |
50 µg |
Ask for price |
|
|
Mouse TIE-1 Fc Chimera (TIE-1 Fc) Protein |
|
abx073608-100tests |
Abbexa |
100 tests |
EUR 225 |
Mouse TIE-1 Fc Chimera (TIE-1 Fc) Protein |
|
abx073608-1920tests |
Abbexa |
1920 tests |
EUR 4862.5 |
Mouse TIE-1 Fc Chimera (TIE-1 Fc) Protein |
|
abx073608-400tests |
Abbexa |
400 tests |
EUR 325 |
APC anti-mouse CD202b (Tie-2, CD202) |
|
E16FMA202b-025U |
EnoGene |
25 μg |
EUR 325 |
|
Description: Available in various conjugation types. |
APC anti-mouse CD202b (Tie-2, CD202) |
|
E16FMA202b-100U |
EnoGene |
100 μg |
EUR 953.33 |
|
Description: Available in various conjugation types. |
APC anti-mouse CD202b (Tie-2, CD202) |
|
GT03156 |
Sony |
100 µg |
Ask for price |
|
|
APC anti-mouse CD202b (Tie-2, CD202) |
|
GT03155 |
Sony |
25 µg |
Ask for price |
|
|
Biotin anti-mouse CD202b (Tie-2, CD202) |
|
E16FMB202b-050U |
EnoGene |
50 μg |
EUR 411.67 |
|
Description: Available in various conjugation types. |
Biotin anti-mouse CD202b (Tie-2, CD202) |
|
E16FMB202b-200U |
EnoGene |
200 μg |
EUR 910 |
|
Description: Available in various conjugation types. |
Biotin anti-mouse CD202b (Tie-2, CD202) |
|
GT03151 |
Sony |
50 µg |
Ask for price |
|
|
Biotin anti-mouse CD202b (Tie-2, CD202) |
|
GT03152 |
Sony |
200 µg |
Ask for price |
|
|
Mouse TIE-1, soluble |
|
MBS691933-001mg |
MyBiosource |
0.01mg |
EUR 255 |
Mouse TIE-1, soluble |
|
MBS691933-5x001mg |
MyBiosource |
5x0.01mg |
EUR 865 |
Mouse TIE-1, soluble |
|
MBS692158-005mg |
MyBiosource |
0.05mg |
EUR 430 |
Mouse TIE-1, soluble |
|
MBS692158-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1645 |
Purified anti-mouse CD202b (Tie-2, CD202) |
|
E16FMU202b-050U |
EnoGene |
50 μg |
EUR 325 |
|
Description: Available in various conjugation types. |
Purified anti-mouse CD202b (Tie-2, CD202) |
|
E16FMU202b-100U |
EnoGene |
100 μg |
EUR 650 |
|
Description: Available in various conjugation types. |
Purified anti-mouse CD202b (Tie-2, CD202) |
|
E16FMU202b-200U |
EnoGene |
200 μg |
EUR 801.67 |
|
Description: Available in various conjugation types. |
Purified anti-mouse CD202b (Tie-2, CD202) |
|
E16FMU202b-500U |
EnoGene |
500 μg |
EUR 3250 |
|
Description: Available in various conjugation types. |
Anti-Human TIE-2 Antibody |
|
101-M55 |
ReliaTech |
100 µg |
EUR 399 |
|
Description: Tie-1/Tie and Tie-2/Tek are receptor tyrosine kinases with unique structural characteristics including two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains, followed by three fibronectin type III-like repeats in the extracellular region, and a split tyrosine kinase domain in the cytoplasmic region. Tie-2 is involved in vascular stabilization and remodeling. Although less well understood, Tie-1 may also act as an ANG receptor, possibly in complex with Tie-2. Human Tie-2 cDNA encodes a 1124 amino acid (aa) residue precursor protein with an 18 residue putative signal peptide, a 727 residue extracellular domain and a 354 residue cytoplasmic domain. Tie-2 is a receptor for the angiopoietin (ANG) family: ANG-1, ANG-2, and ANG-3 (mouse)/-4 (human). Ang-2 has been reported to act as an antagonist for Ang-1. Mice engineered to overexpress Ang-2 or to lack Ang-1 or Tie-2 display similar angiogenesis defects. |
Anti-Human TIE-2 Antibody |
|
101-M837 |
ReliaTech |
100 µg |
EUR 399 |
|
Description: Tie-1/Tie and Tie-2/Tek are receptor tyrosine kinases with unique structural characteristics including two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains, followed by three fibronectin type III-like repeats in the extracellular region, and a split tyrosine kinase domain in the cytoplasmic region. Tie-2 is involved in vascular stabilization and remodeling. Although less well understood, Tie-1 may also act as an ANG receptor, possibly in complex with Tie-2. Human Tie-2 cDNA encodes a 1124 amino acid (aa) residue precursor protein with an 18 residue putative signal peptide, a 727 residue extracellular domain and a 354 residue cytoplasmic domain. Tie-2 is a receptor for the angiopoietin (ANG) family: ANG-1, ANG-2, and ANG-3 (mouse)/-4 (human). Ang-2 has been reported to act as an antagonist for Ang-1. Mice engineered to overexpress Ang-2 or to lack Ang-1 or Tie-2 display similar angiogenesis defects. |
Anti-Human TIE-2 Antibody |
|
102-PA111S |
ReliaTech |
100 µg |
EUR 126 |
|
Description: TIE-1 (tyrosine kinase with Ig and EGF homology domains 1) and TIE-2/TEK comprise a receptor tyrosine kinase (RTK) subfamily with unique structural characteristics: two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains and followed by three fibronectin type III-like repeats in the extracellular region and a split tyrosine kinase domain in the cytoplasmic region. These receptors are expressed primarily on endothelial and hematopoietic progenitor cells and play critical roles in angiogenesis, vasculogenesis and hematopoiesis. Human TIE-2 cDNA encodes a 1124 amino acid (aa) residue precursor protein with an 18 residue putative signal peptide, a 727 residue extracellular domain and a 354 residue cytoplasmic domain. Two ligands, angiopoietin-1 (Ang1) and angiopoietin-2 (Ang2), which bind TIE-2 with high affinity have been identified. Ang2 has been reported to act as an antagonist for Ang1. Mice engineered to overexpress Ang2 or to lack Ang1 or TIE-2 display similar angiogenic defects. |
Anti-Human Tie-2 Antibody |
|
MBS4158498-01mg |
MyBiosource |
0.1mg |
EUR 920 |
Anti-Human Tie-2 Antibody |
|
MBS4158498-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3880 |
Recombinant Mouse TIE-2-Fc chimeric protein |
|
TIE26-R-100 |
Alpha Diagnostics |
100 ug |
EUR 1074 |
Recombinant Mouse TIE-2-Fc chimeric protein |
|
TIE26-R-20 |
Alpha Diagnostics |
20 ug |
EUR 343.2 |
Anti-Mouse TIE-1 Antibody |
|
103-PA110S |
ReliaTech |
100 µg |
EUR 126 |
|
Description: TIE-1 (tyrosine kinase with Ig and EGF homology domains 1) and TIE-2/Tek comprise a receptor tyrosine kinase (RTK) subfamily with unique structural characteristics: two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains and followed by three fibronectin type III-like repeats in the extracellular region and a split tyrosine kinase domain in the cytoplasmic region. These receptors are expressed primarily on endothelial and hematopoietic progenitor cells and play critical roles in angiogenesis, vasculogenesis and hematopoiesis. |
Mouse Anti-Human Tie-1 monoclonal antibody, clone NN14 |
|
CABT-ZB743 |
Creative Diagnostics |
50 μl |
EUR 456 |
|
|
|
Description: Mouse |
Mouse Anti-Human Tie-1 monoclonal antibody, clone NN19 |
|
CABT-ZB1060 |
Creative Diagnostics |
50 μl |
EUR 456 |
|
|
|
Description: Mouse |
Mouse Total Tie-2 ELISA Kit Intracellular |
|
NR-E10798 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
- 96 Tests
- 2x 96 Tests
- 4x 96 Tests
|
Anti-Human TIE-2-PE Antibody |
|
101-M54-PE |
ReliaTech |
50 µg |
Ask for price |
|
Description: Tie-1/Tie and Tie-2/Tek are receptor tyrosine kinases with unique structural characteristics including two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains, followed by three fibronectin type III-like repeats in the extracellular region, and a split tyrosine kinase domain in the cytoplasmic region. Tie-2 is involved in vascular stabilization and remodeling. Although less well understood, Tie-1 may also act as an ANG receptor, possibly in complex with Tie-2. Human Tie-2 cDNA encodes a 1124 amino acid (aa) residue precursor protein with an 18 residue putative signal peptide, a 727 residue extracellular domain and a 354 residue cytoplasmic domain. Tie-2 is a receptor for the angiopoietin (ANG) family: ANG-1, ANG-2, and ANG-3 (mouse)/-4 (human). Ang-2 has been reported to act as an antagonist for Ang-1. Mice engineered to overexpress Ang-2 or to lack Ang-1 or Tie-2 display similar angiogenesis defects. |
Anti-Human TIE-2-PE Antibody |
|
101-M54S-PE |
ReliaTech |
25 µg |
Ask for price |
|
Description: Tie-1/Tie and Tie-2/Tek are receptor tyrosine kinases with unique structural characteristics including two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains, followed by three fibronectin type III-like repeats in the extracellular region, and a split tyrosine kinase domain in the cytoplasmic region. Tie-2 is involved in vascular stabilization and remodeling. Although less well understood, Tie-1 may also act as an ANG receptor, possibly in complex with Tie-2. Human Tie-2 cDNA encodes a 1124 amino acid (aa) residue precursor protein with an 18 residue putative signal peptide, a 727 residue extracellular domain and a 354 residue cytoplasmic domain. Tie-2 is a receptor for the angiopoietin (ANG) family: ANG-1, ANG-2, and ANG-3 (mouse)/-4 (human). Ang-2 has been reported to act as an antagonist for Ang-1. Mice engineered to overexpress Ang-2 or to lack Ang-1 or Tie-2 display similar angiogenesis defects. |
Anti- TIE-2 N-terminal Antibody |
|
GWB-1C40EA |
GenWay Biotech |
0.1 mg |
Ask for price |
|
|
Anti-Human TIE-2-FITC Antibody |
|
101-M54-FITC |
ReliaTech |
50 µg |
Ask for price |
|
Description: Tie-1/Tie and Tie-2/Tek are receptor tyrosine kinases with unique structural characteristics including two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains, followed by three fibronectin type III-like repeats in the extracellular region, and a split tyrosine kinase domain in the cytoplasmic region. Tie-2 is involved in vascular stabilization and remodeling. Although less well understood, Tie-1 may also act as an ANG receptor, possibly in complex with Tie-2. Human Tie-2 cDNA encodes a 1124 amino acid (aa) residue precursor protein with an 18 residue putative signal peptide, a 727 residue extracellular domain and a 354 residue cytoplasmic domain. Tie-2 is a receptor for the angiopoietin (ANG) family: ANG-1, ANG-2, and ANG-3 (mouse)/-4 (human). Ang-2 has been reported to act as an antagonist for Ang-1. Mice engineered to overexpress Ang-2 or to lack Ang-1 or Tie-2 display similar angiogenesis defects. |
Anti-Human TIE-2-FITC Antibody |
|
101-M54S-FITC |
ReliaTech |
25 µg |
Ask for price |
|
Description: Tie-1/Tie and Tie-2/Tek are receptor tyrosine kinases with unique structural characteristics including two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains, followed by three fibronectin type III-like repeats in the extracellular region, and a split tyrosine kinase domain in the cytoplasmic region. Tie-2 is involved in vascular stabilization and remodeling. Although less well understood, Tie-1 may also act as an ANG receptor, possibly in complex with Tie-2. Human Tie-2 cDNA encodes a 1124 amino acid (aa) residue precursor protein with an 18 residue putative signal peptide, a 727 residue extracellular domain and a 354 residue cytoplasmic domain. Tie-2 is a receptor for the angiopoietin (ANG) family: ANG-1, ANG-2, and ANG-3 (mouse)/-4 (human). Ang-2 has been reported to act as an antagonist for Ang-1. Mice engineered to overexpress Ang-2 or to lack Ang-1 or Tie-2 display similar angiogenesis defects. |
Tie-2 Antibody |
|
45046-100ul |
SAB |
100ul |
EUR 302.4 |
Tie-2 Antibody |
|
45046-50ul |
SAB |
50ul |
EUR 224.4 |
Tie-2 Antibody |
|
B8192-100ul |
Assay Biotech |
100μl |
EUR 217 |
|
Description: Tie-2 Rabbit Polyclonal Antibody |
Tie-2 Antibody |
|
B8192-50ul |
Assay Biotech |
50μl |
EUR 143.5 |
|
Description: Tie-2 Rabbit Polyclonal Antibody |
Tie-2 Antibody |
|
E19-7500-1 |
EnoGene |
50ug/50ul |
EUR 145 |
|
Description: Available in various conjugation types. |
Tie-2 Antibody |
|
E19-7500-2 |
EnoGene |
100ug/100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
Tie-2 Antibody |
|
MBS9608110-01mL |
MyBiosource |
0.1mL |
EUR 260 |
Tie-2 Antibody |
|
MBS9608110-02mL |
MyBiosource |
0.2mL |
EUR 305 |
Tie-2 Antibody |
|
MBS9608110-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1220 |
Tie-2 Antibody |
|
MBS8516906-005mg |
MyBiosource |
0.05mg |
EUR 235 |
Tie-2 Antibody |
|
MBS8516906-01mg |
MyBiosource |
0.1mg |
EUR 305 |
Tie-2 Antibody |
|
MBS8516906-01mLAF405M |
MyBiosource |
0.1mL(AF405M) |
EUR 465 |
Tie-2 Antibody |
|
MBS8516906-01mLAF546 |
MyBiosource |
0.1mL(AF546) |
EUR 465 |
Tie-2 Antibody |
|
MBS8516906-01mLAF750 |
MyBiosource |
0.1mL(AF750) |
EUR 465 |
Mouse Angiopoietin-1 receptor,Tie-2 ELISA KIT |
|
JOT-EK0211Mo |
Jotbody |
96 wells |
Ask for price |
|
Description: Mouse |
Rat Monoclonal anti-Mouse CD202b (Tie-2, CD202) Antibody |
|
xAP-0575 |
Angio Proteomie |
100ug |
EUR 280 |
Mouse TIE-1/Fc Chimera, soluble |
|
MBS691584-002mg |
MyBiosource |
0.02mg |
EUR 255 |
Mouse TIE-1/Fc Chimera, soluble |
|
MBS691584-5x002mg |
MyBiosource |
5x0.02mg |
EUR 865 |
Mouse TIE-1/Fc Chimera, soluble |
|
MBS692035-01mg |
MyBiosource |
0.1mg |
EUR 430 |
Mouse TIE-1/Fc Chimera, soluble |
|
MBS692035-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1645 |
Anti-Human TIE-2/tek (Ci. 2) Antibody |
|
MBS4158545-01mg |
MyBiosource |
0.1mg |
EUR 920 |
Anti-Human TIE-2/tek (Ci. 2) Antibody |
|
MBS4158545-5x01mg |
MyBiosource |
5x0.1mg |
EUR 3880 |
Recombinant Mouse TIE-1 Fc Chimera |
|
7-04186 |
CHI Scientific |
1µg |
Ask for price |
Recombinant Mouse TIE-1 Fc Chimera |
|
7-04187 |
CHI Scientific |
3µg |
Ask for price |
Recombinant Mouse TIE-1 Fc Chimera |
|
7-04188 |
CHI Scientific |
100µg |
Ask for price |
Recombinant Mouse TIE-1 Fc Chimera |
|
MBS142793-0002mg |
MyBiosource |
0.002mg |
EUR 240 |
Recombinant Mouse TIE-1 Fc Chimera |
|
MBS142793-001mg |
MyBiosource |
0.01mg |
EUR 310 |
Recombinant Mouse TIE-1 Fc Chimera |
|
MBS142793-1mg |
MyBiosource |
1mg |
EUR 3975 |
Recombinant Mouse TIE-1 Fc Chimera |
|
MBS142793-5x1mg |
MyBiosource |
5x1mg |
EUR 17550 |
Mouse TIE-1, soluble Recombinant Protein |
|
S01-M41 |
ReliaTech |
10 µg |
EUR 68.25 |
|
Description: Recombinant mouse soluble TIE-1 was fused with a 6x His-tag at the C-terminus. The soluble receptor protein consists of the full extracellular domain (Ser22-Ala748). Mouse sTIE-1 monomer has a calculated molecular mass of approximately 79,8 kDa. As a result of glycosylation, the recombinant protein migrates as an approximately 95 kDa protein in SDS-PAGE under reducing conditions. TIE-1 (tyrosine kinase with Ig and EGF homology domains 1) and TIE-2/Tek comprise a receptor tyrosine kinase (RTK) subfamily with unique structural characteristics: two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains and followed by three fibronectin type III-like repeats in the extracellular region and a split tyrosine kinase domain in the cytoplasmic region. These receptors are expressed primarily on endothelial and hematopoietic progenitor cells and play critical roles in angiogenesis, vasculogenesis and hematopoiesis. |
Mouse TIE-1, soluble Recombinant Protein |
|
S01-M42 |
ReliaTech |
50 µg |
EUR 189 |
|
Description: Recombinant mouse soluble TIE-1 was fused with a 6x His-tag at the C-terminus. The soluble receptor protein consists of the full extracellular domain (Ser22-Ala748). Mouse sTIE-1 monomer has a calculated molecular mass of approximately 79,8 kDa. As a result of glycosylation, the recombinant protein migrates as an approximately 95 kDa protein in SDS-PAGE under reducing conditions. TIE-1 (tyrosine kinase with Ig and EGF homology domains 1) and TIE-2/Tek comprise a receptor tyrosine kinase (RTK) subfamily with unique structural characteristics: two immunoglobulin-like domains flanking three epidermal growth factor (EGF)-like domains and followed by three fibronectin type III-like repeats in the extracellular region and a split tyrosine kinase domain in the cytoplasmic region. These receptors are expressed primarily on endothelial and hematopoietic progenitor cells and play critical roles in angiogenesis, vasculogenesis and hematopoiesis. |
Anti-Human CD202b/TEK/TIE-2 Nanobody |
|
MBS1568138-01mg |
MyBiosource |
0.1mg |
EUR 405 |
Anti-Human CD202b/TEK/TIE-2 Nanobody |
|
MBS1568138-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1520 |
Anti-Tie-1 Antibody, Mouse Monoclonal |
|
MBS8103039-01mL |
MyBiosource |
0.1mL |
EUR 300 |
Anti-Tie-1 Antibody, Mouse Monoclonal |
|
MBS8103039-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1200 |
Anti-Tie-1 Antibody, Mouse Monoclonal |
|
MBS8103041-01mL |
MyBiosource |
0.1mL |
EUR 300 |
Anti-Tie-1 Antibody, Mouse Monoclonal |
|
MBS8103041-5x01mL |
MyBiosource |
5x0.1mL |
EUR 1200 |
Purified Mouse TIE-2 (1-744aa) recombinant control protein for WB |
|
TIE24-C |
Alpha Diagnostics |
100 ul |
EUR 343.2 |
Tie-2 Polyclonal Antibody |
|
ABP56367-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
|
|
Description: A polyclonal antibody for detection of Tie-2 from Human, Mouse. This Tie-2 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Tie-2 around the non-phosphorylation site of Y1102 |
Tie-2 Polyclonal Antibody |
|
ABP56367-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
|
|
Description: A polyclonal antibody for detection of Tie-2 from Human, Mouse. This Tie-2 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Tie-2 around the non-phosphorylation site of Y1102 |
Tie-2 Polyclonal Antibody |
|
ABP56367-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
|
|
Description: A polyclonal antibody for detection of Tie-2 from Human, Mouse. This Tie-2 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Tie-2 around the non-phosphorylation site of Y1102 |
Tie-2 Polyclonal Antibody |
|
ABP56368-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
|
|
Description: A polyclonal antibody for detection of Tie-2 from Human, Mouse. This Tie-2 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Tie-2 around the non-phosphorylation site of Y992 |
Tie-2 Polyclonal Antibody |
|
ABP56368-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
|
|
Description: A polyclonal antibody for detection of Tie-2 from Human, Mouse. This Tie-2 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Tie-2 around the non-phosphorylation site of Y992 |
Tie-2 Polyclonal Antibody |
|
ABP56368-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
|
|
Description: A polyclonal antibody for detection of Tie-2 from Human, Mouse. This Tie-2 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Tie-2 around the non-phosphorylation site of Y992 |
Tie-2 Polyclonal Antibody |
|
BT-AP09017-100ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
100ul |
Ask for price |
|
|
|
Description: TEK (TEK receptor tyrosine kinase) encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in TEK are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of TEK have been described, but their full-length nature is not known. |
Tie-2 Polyclonal Antibody |
|
BT-AP09017-20ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
20ul |
Ask for price |
|
|
|
Description: TEK (TEK receptor tyrosine kinase) encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in TEK are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of TEK have been described, but their full-length nature is not known. |
Tie-2 Polyclonal Antibody |
|
BT-AP09017-50ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
50ul |
Ask for price |
|
|
|
Description: TEK (TEK receptor tyrosine kinase) encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in TEK are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of TEK have been described, but their full-length nature is not known. |
Tie-2 Polyclonal Antibody |
|
BT-AP09018-100ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
100ul |
Ask for price |
|
|
|
Description: TEK (TEK receptor tyrosine kinase) encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in TEK are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of TEK have been described, but their full-length nature is not known. |
Tie-2 Polyclonal Antibody |
|
BT-AP09018-20ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
20ul |
Ask for price |
|
|
|
Description: TEK (TEK receptor tyrosine kinase) encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in TEK are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of TEK have been described, but their full-length nature is not known. |
Tie-2 Polyclonal Antibody |
|
BT-AP09018-50ul |
Jiaxing Korain Biotech Ltd (BT Labs) |
50ul |
Ask for price |
|
|
|
Description: TEK (TEK receptor tyrosine kinase) encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in TEK are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of TEK have been described, but their full-length nature is not known. |
Tie-2 Conjugated Antibody |
|
C45046 |
SAB |
100ul |
EUR 476.4 |
Tie-2 Polyclonal Antibody |
|
JOT-AP09017-100ul |
Jotbody |
100ul |
EUR 220 |
|
|
|
Description: Human;Mouse |
Tie-2 Polyclonal Antibody |
|
JOT-AP09017-50ul |
Jotbody |
50ul |
EUR 144 |
|
|
|
Description: Human;Mouse |
Tie-2 Polyclonal Antibody |
|
JOT-AP09018-100ul |
Jotbody |
100ul |
EUR 220 |
|
|
|
Description: Human;Mouse |
Tie-2 Polyclonal Antibody |
|
JOT-AP09018-50ul |
Jotbody |
50ul |
EUR 144 |
|
|
|
Description: Human;Mouse |
On this examine, we described a brand new strategy and approach that could be utilized for differentiation of BMSCs to chondrocyte as a substitute of stimulation with TGFβ3. Our information implies that miR-140 is a potent chondrogenic differentiation inducer for BMSCs, and we now have proven growing chondrogenic differentiation through the use of miR-140 overexpression.